HIGHER AUTOANTIBODY LEVELS AND RECOGNITION OF A LINEAR NH2-TERMINAL EPITOPE IN THE AUTOANTIGEN GAD(65), DISTINGUISH STIFF-MAN SYNDROME FROM INSULIN-DEPENDENT DIABETES-MELLITUS

被引:170
作者
KIM, J
NAMCHUK, M
BUGAWAN, T
FU, Q
JAFFE, M
SHI, YG
AANSTOOT, HJ
TURCK, CW
ERLICH, H
LENNON, V
BAEKKESKOV, S
机构
[1] UNIV CALIF SAN FRANCISCO, HORMONE RES INST, DEPT MED, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF SAN FRANCISCO, HORMONE RES INST, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA
[3] ROCHE MOLEC SYST, DEPT HUMAN GENET, ALAMEDA, CA 94501 USA
[4] UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, SAN FRANCISCO, CA 94143 USA
[5] UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA
[6] MAYO CLIN & MAYO FDN, SCH MED, DEPT NEUROL, ROCHESTER, MN 55905 USA
[7] MAYO CLIN & MAYO FDN, SCH MED, DEPT IMMUNOL, ROCHESTER, MN 55905 USA
[8] MAYO CLIN & MAYO FDN, SCH MED, DEP LAB MED PATHOL, ROCHESTER, MN 55905 USA
关键词
D O I
10.1084/jem.180.2.595
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The smaller form of the GABA-synthesizing enzyme glutamic acid decarboxylase (GAD(65)) is a major autoantigen in two human diseases that affect its principal sites of expression. Thus, destruction of pancreatic beta cells, which results in insulin-dependent diabetes mellitus (IDDM), and impairment of GABA-ergic synaptic transmission in Stiff-Man syndrome (SMS) are both characterized by circulating autoantibodies to GAD(65) Anti-GAD(65) autoantibodies in IDDM are predominantly directed to conformational epitopes. Here we report the characterization of humoral autoimmune responses to GAD(65) in 35 SMS patients, of whom 13 (37%) also had IDDM. All SMS patients immunoprecipitated native GAD(65) and the main titers were orders of magnitude higher than in IDDM patients. Furthermore, in contrast to the situation in IDDM, autoantibodies in 35 of 35 (100%) of SMS patients recognized denatured GAD(65) on Western blots. Two major patterns of epitope specificity were identified on Western blots. The first pattern, detected in 25 of 35 SMS patients (71%), of whom 11 had IDDM (44%), was predominantly reactive with a linear NH2-terminal epitope residing in the first eight amino acids of GAD(65). Nine of nine individuals who were HLA-haplotyped in this group carried an IDDM susceptibility haplotype and HLA-DR3, DQw2 was particularly abundant. The second pattern, detected in 10 of 35 patients (29%) of whom two had IDDM (20%), included reactivity with the NH2-terminal epitope plus strong reactivity with one or more additional epitope(s) residing COOH-terminal to amino acid 101. The second epitope pattern may represent epitope spreading in the GAD(65) molecule, but may also include some cases of epitope recognition associated with IDDM resistant HLA-haplotypes. The principal NH2-terminal linear epitope in GAD(65) distinguishes the reactivity of SMS and IDDM autoantibodies and may be a determinant of pathogenicity for GABA-ergic neurons. The greater magnitude and distinct specificity of the humoral response to GAD(65) in SMS may reflect a biased involvement of the T helper cell type 2 (Th2) subset of CD4(+) T cells and antibody responses, whereas IDDM is likely mediated by the Th1 subset of CD4(+) T cells and cytotoxic T cell responses.
引用
收藏
页码:595 / 606
页数:12
相关论文
共 43 条
[21]   AUTOANTIBODIES IN IDDM PRIMARILY RECOGNIZE THE 65,000-MR RATHER THAN THE 67,000-MR ISOFORM OF GLUTAMIC-ACID DECARBOXYLASE [J].
HAGOPIAN, WA ;
CHELSEN, BM ;
KARLSEN, AE ;
LARSEN, F ;
MOODY, A ;
GRUBIN, CE ;
ROWE, R ;
PETERSEN, J ;
MCEVOY, R ;
LERNMARK, A .
DIABETES, 1993, 42 (04) :631-636
[22]   RECOMBINANT GLUTAMIC-ACID DECARBOXYLASE (REPRESENTING THE SINGLE ISOFORM EXPRESSED IN HUMAN ISLETS) DETECTS IDDM-ASSOCIATED 64,000-MR AUTOANTIBODIES [J].
KARLSEN, AE ;
HAGOPIAN, WA ;
PETERSEN, JS ;
BOEL, E ;
DYRBERG, T ;
GRUBIN, CE ;
MICHELSEN, BK ;
MADSEN, OD ;
LERNMARK, A .
DIABETES, 1992, 41 (10) :1355-1359
[23]   SPONTANEOUS LOSS OF T-CELL TOLERANCE TO GLUTAMIC-ACID DECARBOXYLASE IN MURINE INSULIN-DEPENDENT DIABETES [J].
KAUFMAN, DL ;
CLARESALZLER, M ;
TIAN, JD ;
FORSTHUBER, T ;
TING, GSP ;
ROBINSON, P ;
ATKINSON, MA ;
SERCARZ, EE ;
TOBIN, AJ ;
LEHMANN, PV .
NATURE, 1993, 366 (6450) :69-72
[24]   DIFFERENTIAL EXPRESSION OF GAD(65) AND GAD(67) IN HUMAN, RAT, AND MOUSE PANCREATIC-ISLETS [J].
KIM, J ;
RICHTER, W ;
AANSTOOT, HJ ;
SHI, YG ;
FU, Q ;
RAJOTTE, R ;
WARNOCK, G ;
BAEKKESKOV, S .
DIABETES, 1993, 42 (12) :1799-1808
[25]   ISLET CELL AND THYROGASTRIC ANTIBODIES IN 633 CONSECUTIVE 15-YR-OLD TO 34-YR-OLD PATIENTS IN THE DIABETES INCIDENCE STUDY IN SWEDEN [J].
LANDINOLSSON, M ;
KARLSSON, FA ;
LERNMARK, A ;
SUNDKVIST, G ;
ARNQVIST, H ;
BLOHME, G ;
LITHNER, F ;
LITTORIN, B ;
NYSTROM, L ;
ROSENQVIST, U ;
SCHERSTEN, B ;
WIBELL, L ;
OSTMAN, J .
DIABETES, 1992, 41 (08) :1022-1027
[26]   ANTIGEN UPTAKE AND ACCUMULATION IN ANTIGEN-SPECIFIC B-CELLS [J].
LANZAVECCHIA, A .
IMMUNOLOGICAL REVIEWS, 1987, 99 :39-51
[27]   STIFF-MAN SYNDROME UPDATED [J].
LORISH, TR ;
THORSTEINSSON, G ;
HOWARD, FM .
MAYO CLINIC PROCEEDINGS, 1989, 64 (06) :629-636
[28]   CHARACTERIZATION OF A LINEAR EPITOPE WITHIN THE HUMAN PANCREATIC 64-KDA GLUTAMIC-ACID DECARBOXYLASE AND ITS AUTOIMMUNE RECOGNITION BY SERA FROM INSULIN-DEPENDENT DIABETES-MELLITUS PATIENTS [J].
MAUCH, L ;
ABNEY, CC ;
BERG, H ;
SCHERBAUM, WA ;
LIEDVOGEL, B ;
NORTHEMANN, W .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 212 (02) :597-603
[29]   CLONING, CHARACTERIZATION, AND AUTOIMMUNE RECOGNITION OF RAT ISLET GLUTAMIC-ACID DECARBOXYLASE IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
MICHELSEN, BK ;
PETERSEN, JS ;
BOEL, E ;
MOLDRUP, A ;
DYRBERG, T ;
MADSEN, OD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8754-8758
[30]  
MOERSCH FP, 1956, P STAFF M MAYO CLIN, V31, P421